KromaTiD awarded Direct to Phase II SBIR grant by the National Human Genome Research Institute

KromaTiD awarded Direct to Phase II SBIR grant by the National Human Genome Research Institute

LONGMONT -- KromaTiD, Inc. today announced it has been awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural... Read More

Monday August 24, 2020 0 comments Tags: Longmont, KromaTid, National Human Genome Research Institute, Christopher Tompkins

IN Sponsors

Content Garden ad

Browse

The human perspective
The human perspective
FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients
FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients
CBSA sets virtual Life Sciences Innovation Forum for Sept. 30-Oct. 1
CBSA sets virtual Life Sciences Innovation Forum for Sept. 30-Oct. 1
CSU chemist seeks to build a better way to make COVID-19 drug, using light
CSU chemist seeks to build a better way to make COVID-19 drug, using light
Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020
Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.